The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).
about
The role of physical rehabilitation in stem cell transplantation patientsSleep Patterns During Hospitalization Following Hematopoietic Stem Cell TransplantationInterdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study.Music therapy for patients who have undergone hematopoietic stem cell transplant.Effects of nonpharmacological interventions on reducing fatigue after hematopoietic stem cell transplantation.An individualized dyadic problem-solving education intervention for patients and family caregivers during allogeneic hematopoietic stem cell transplantation: a feasibility study.Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical managementSleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates.Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantationStrength training following hematopoietic stem cell transplantation.A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatmentInformal caregiving in Hematopoietic Blood and Marrow Transplant patients.Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cCaregiving burden, stress, and health effects among family caregivers of adult cancer patients.Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics.Symptom prevalence and physiologic biomarkers among adolescents using a mobile phone intervention following hematopoietic stem cell transplantation.Feasibility of a symptom management intervention for adolescents recovering from a hematopoietic stem cell transplant.Health-related quality of life following allogeneic hematopoietic stem cell transplantation.Functional evaluation indicates physical losses after hematopoietic stem cell transplantationFeasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.Effectiveness of partner social support predicts enduring psychological distress after hematopoietic stem cell transplantation.Radiofrequency thermocoagulation for V2/V3 idiopathic trigeminal neuralgia: effect of treatment temperatures on long-term clinical outcomes: A Cohort Study.Discharge needs of allogeneic transplantation recipientsSymptoms and Quality of Life: Before and after stem cell transplantation in cancerNon-myeloablative allogeneic hematopoietic stem cell transplantation.Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study.Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatologyDetermination of burnout levels of nurses working in stem cell transplantation units in Turkey.Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study.Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis.Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue.Disparities in cancer care: perspectives from the front line.Long-term effect of the self-management comprehensive coping strategy program on quality of life in patients with breast cancer treated with high-dose chemotherapy.The psychosocial impact of haematopoietic SCT on sibling donors.Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation.
P2860
Q28087720-CDFFCDD0-EBC4-4B2C-AD24-DA648102E45AQ28386551-214A3015-6929-4999-8410-EEB1A9EB1D78Q30315577-C2DDE59F-0710-42C5-A54F-066D0CAF24E9Q30358967-A58685F3-3E51-4F11-824C-6B3DA40BC031Q30401528-BB79514E-1C95-4778-9481-1DFF5E24938DQ33775787-77A68C6B-7F59-4E77-ADE3-2A33891721EDQ33949546-44271E65-E28B-41FD-ADE1-5B696616D380Q34175300-111B1102-7950-4104-82EE-BA750FC0C8BEQ34458775-E84B9930-2A99-4BE6-8777-7570023DFD2EQ34729742-1224B223-2E57-4412-8285-2AB6A619BAFAQ34904592-049A51D2-5C65-445D-B0BD-EDBFDB392383Q34987417-84A9F6CC-579D-4A49-ACC4-4580E58B3877Q35038188-9CCEDCA7-BAD4-40EC-8B76-4C95E4AE692CQ35765750-1BC1FD79-CE1D-431F-9F55-098A32626F2FQ35832813-CD8AD6D0-7ADC-4964-A280-25B732527A3CQ36087195-3B52D889-7FB1-42FD-8CE5-5B2D64FF413BQ36121760-52861961-818B-4C59-B7FF-A0EA05852244Q36121772-6A03B835-EAEE-4C15-A2F9-ED486BE228D1Q36286379-5E5E9BD2-7D38-45ED-A1AA-D3FF8F77BF65Q36364830-5E937A8E-0563-4FFC-9E73-B420F0181A2EQ36740168-1FE84FBB-3541-4B30-AF8C-0AFB57AFBF7AQ36950649-5BC159D3-8F79-4D5C-A62F-AB22C54BDB99Q37077989-67844F27-D390-414B-95C8-CC8CEE99F82DQ37200543-85ABA483-6610-406C-A9A4-4B8F23002C37Q37258003-E19E472D-1322-49A9-B900-79322A63F743Q37308127-E5922684-1078-4C39-B70B-E1A085FB6005Q37656904-3025F820-1FF8-4177-9540-0225DA8B1E5EQ38203303-715A0F79-6D41-4E17-AAB0-25CD3BCD354BQ38751585-F1813667-317D-42ED-A13E-0FB88F0B6AA8Q39176991-F9CF4DBB-5C79-429C-A3CC-153A85C60AECQ39829380-29776524-5D14-4024-8666-72DBD075C32EQ39965532-E0CAF889-4313-4157-98DE-E05EDD7C7E7AQ40948883-34A21378-70C0-422B-BA6C-447482A04A54Q41157348-BE5F7436-50ED-4996-964C-5ABF002300D8Q41333675-FFB9013F-C905-483A-AA3D-16D252226CB4Q42324641-9083AFBA-932F-481D-8AD0-1B5928D9A3F0Q44573149-A4D11212-1D09-46EB-9CE0-360C8E3F46F0Q44736309-34EE7C7A-B88A-4A4A-A4EC-1C931FEAC6D1Q44848919-23247269-C57F-40E5-9468-2F49BF15D182Q46866626-311054F1-B70E-4981-BFA5-D287D22FCB8D
P2860
The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The symptom experience in the ...... m cell transplantation (HSCT).
@ast
The symptom experience in the ...... m cell transplantation (HSCT).
@en
type
label
The symptom experience in the ...... m cell transplantation (HSCT).
@ast
The symptom experience in the ...... m cell transplantation (HSCT).
@en
prefLabel
The symptom experience in the ...... m cell transplantation (HSCT).
@ast
The symptom experience in the ...... m cell transplantation (HSCT).
@en
P2093
P2860
P1476
The symptom experience in the ...... m cell transplantation (HSCT).
@en
P2093
Margaret F Bevans
Sandra A Mitchell
Susan Marden
P2860
P2888
P304
P356
10.1007/S00520-008-0420-6
P577
2008-03-06T00:00:00Z